Transfer and metabolism of cortisol by the isolated perfused human placenta

Journal of Clinical Endocrinology and Metabolism

Volumn 103, Issue 2, 2018, Pages 640-648

  Stirrat, Laura I ^a   Sengers, Bram G ^b   Norman, Jane E ^a   Homer, Natalie Z M ^a,c   Andrew, Ruth ^a,c   Lewis, Rohan M ^b,d   Reynolds, Rebecca M ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; HYDROCORTISONE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CESAREAN SECTION; CONTROLLED STUDY; ELECTIVE SURGERY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; PLACENTA; PLACENTA PERFUSION; PREGNANCY; PRIORITY JOURNAL; VEIN BLOOD FLOW; BIRTH WEIGHT; MENTAL STRESS; METABOLISM; MOTHER FETUS RELATIONSHIP; NEWBORN; ORGAN CULTURE TECHNIQUE; PERFUSION; PHYSIOLOGY; PLACENTA CIRCULATION; THIRD TRIMESTER PREGNANCY; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; BIOLOGICAL TRANSPORT; BIRTH WEIGHT; FEMALE; HUMANS; HYDROCORTISONE; INFANT, NEWBORN; MATERNAL-FETAL RELATIONS; ORGAN CULTURE TECHNIQUES; PERFUSION; PLACENTA; PLACENTAL CIRCULATION; PREGNANCY; PREGNANCY TRIMESTER, THIRD; STRESS, PSYCHOLOGICAL;

EID: 85041918876     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-02140     Document Type: Article

References (37)

1. Stewart PM, Rogerson FM, Mason JI. Type 2 11 betahydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab. 1995;80(3):885-890.
2. Reynolds RM. Glucocorticoid excess and the developmental origins of disease: Two decades of testing the hypothesis-2012 Curt Richter Award Winner. Psychoneuroendocrinology. 2013;38(1): 1-11.
3. Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, Lewis JG, Czajko RJ, Inder WJ. Alongitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011;96(5): 1533-1540.
4. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res. 1973;7(5):509-519.
5. Brown RW, Chapman KE, Edwards CR, Seckl JR. Human placental 11 beta-hydroxysteroid dehydrogenase: Evidence for and partial purification of a distinct NAD-dependent isoform. Endocrinology. 1993;132(6):2614-2621.
6. Brown RW, Diaz R, Robson AC, Kotelevtsev YV, Mullins JJ, Kaufman MH, Seckl JR. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology. 1996;137(2):794-797.
7. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11 betahydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab. 1995;80(7):2203-2209.
8. Chapman K, Holmes M, Seckl J. 11b-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev. 2013;93(3):1139-1206.
9. Cottrell EC, Holmes MC, Livingstone DE, Kenyon CJ, Seckl JR. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming. FASEB J. 2012;26(5):1866-1874.
10. Benediktsson R, Calder AA, Edwards CR, Seckl JR. Placental 11 beta-hydroxysteroid dehydrogenase: A key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf). 1997;46(2): 161-166.
11. Sun K, Yang K, Challis JR. Differential expression of 11 betahydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. J Clin Endocrinol Metab. 1997;82(1): 300-305.
12. Reynolds RM, Pesonen AK, O'Reilly JR, Tuovinen S, Lahti M, Kajantie E, Villa PM, Laivuori H, Hämaläinen E, Seckl JR, Räikkönen K. Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity. Psychol Med. 2015;45(10):2023-2030.
13. Räikkönen K, Pesonen AK, O'Reilly JR, Tuovinen S, Lahti M, Kajantie E, Villa P, Laivuori H, Hämäläinen E, Seckl JR, Reynolds RM. Maternal depressive symptoms during pregnancy, placental expression of genes regulating glucocorticoid and serotonin function and infant regulatory behaviors. Psychol Med. 2015;45(15): 3217-3226.
14. Sengers BG, Please CP, Lewis RM. Computational modelling of amino acid transfer interactions in the placenta. Exp Physiol. 2010; 95(7):829-840.
15. Panitchob N, Widdows KL, Crocker IP, Hanson MA, Johnstone ED, Please CP, Sibley CP, Glazier JD, Lewis RM, Sengers BG. Computational modelling of amino acid exchange and facilitated transport in placental membrane vesicles. J Theor Biol. 2015;365: 352-364.
16. Perazzolo S, Hirschmugl B, Wadsack C, Desoye G, Lewis RM, Sengers BG. The influence of placental metabolism on fatty acid transfer to the fetus. J Lipid Res. 2017;58(2):443-454.
17. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol. 1972;114(6):822-828.
18. Cleal JK, Brownbill P, Godfrey KM, Jackson JM, Jackson AA, Sibley CP, Hanson MA, Lewis RM. Modification of fetal plasma amino acid composition by placental amino acid exchangers in vitro. J Physiol. 2007;582(Pt 2):871-882.
19. Andrew R, Smith K, Jones GC, Walker BR. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. J Clin Endocrinol Metab. 2002;87(1): 277-285.
20. Stirrat LI, O'Reilly JR, Barr SM, Andrew R, Riley SC, Howie AF, Bowman M, Smith R, Lewis JG, Denison FC, Forbes S, Seckl JR, Walker BR, Norman JE, Reynolds RM. Decreased maternal hypothalamic-pituitary-Adrenal axis activity in very severely obese pregnancy: Associations with birthweight and gestation at delivery. Psychoneuroendocrinology. 2016;63:135-143.
21. Panitchob N, Widdows KL, Crocker IP, Johnstone ED, Please CP, Sibley CP, Glazier JD, Lewis RM, Sengers BG. Computational modelling of placental amino acid transfer as an integrated system. Biochim Biophys Acta 2016;1858(7 Pt A):1451-1461.
22. Murphy VE, Clifton VL. Alterations in human placental 11betahydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. Placenta. 2003;24(7):739-744.
23. O'Donnell KJ, Bugge Jensen A, Freeman L, Khalife N, O'Connor TG, Glover V. Maternal prenatal anxiety and downregulation of placental 11b-HSD2. Psychoneuroendocrinology. 2012;37(6): 818-826.
24. Räikkönen K, Pesonen AK, Heinonen K, Lahti J, Komsi N, Eriksson JG, Seckl JR, Jarvenpää AL, Strandberg TE. Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am J Epidemiol. 2009;170(9):1137-1146.
25. Räikkönen K, Martikainen S, Pesonen AK, Lahti J, Heinonen K, Pyhälä R, Lahti M, Tuovinen S, Wehkalampi K, Sammallahti S, Kuula L, Andersson S, Eriksson JG, Ortega-Alonso A, Reynolds RM, Strandberg TE, Seckl JR, Kajantie E. Maternal licorice consumption during pregnancy and pubertal, cognitive, and psychiatric outcomes in children.Am J Epidemiol. 2017;185(5):317-328.
26. St-Pierre MV, Serrano MA, Macias RI, Dubs U, Hoechli M, Lauper U, Meier PJ, Marin JJ. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol. 2000;279(4):R1495-R1503.
27. Yeboah D, Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol. 2006;84(12): 1251-1258.
28. Iqbal M, Audette MC, Petropoulos S, Gibb W, Matthews SG. Placental drug transporters and their role in fetal protection. Placenta. 2012;33(3):137-142.
29. Kalabis GM, Kostaki A, Andrews MH, Petropoulos S, Gibb W, Matthews SG. Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod. 2005;73(4): 591-597.
30. Pascolo L, Fernetti C, Pirulli D, Crovella S, Amoroso A, Tiribelli C. Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem Biophys Res Commun. 2003;303(1):259-265.
31. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta. 2006;27(6-7):602-609.
32. Huang X, Jain A, Baumann M, Körner M, Surbek D, Bütikofer P, Albrecht C. Increased placental phospholipid levels in preeclamptic pregnancies. Int J Mol Sci. 2013;14(2):3487-3499.
33. Hammond GL. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol. 2016;230(1): R13-R25.
34. Phillips RJ, Fortier MA, Ĺopez Bernal A. Prostaglandin pathway gene expression in human placenta, amnion and choriodecidua is differentially affected by preterm and term labour and by uterine inflammation. BMC Pregnancy Childbirth. 2014;14(1):241.
35. Hughes KA, Manolopoulos KN, Iqbal J, Cruden NL, Stimson RH, Reynolds RM, Newby DE, Andrew R, Karpe F, Walker BR. Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo. Diabetes. 2012;61(6):1357-1364.
36. Goedhart G, Vrijkotte TG, Roseboom TJ, van der Wal MF, Cuijpers P, Bonsel GJ. Maternal cortisol and offspring birthweight: Results from a large prospective cohort study. Psychoneuroendocrinology. 2010;35(5):644-652.
37. Baibazarova E, van de Beek C, Cohen-Kettenis PT, Buitelaar J, Shelton KH, van Goozen SH. Influence of prenatal maternal stress, maternal plasma cortisol and cortisol in the amniotic fluid on birth outcomes and child temperament at 3 months. Psychoneuroendocrinology. 2013;38(6):907-915.